MENU
FMS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

FMS stock forecast, quote, news & analysis

Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
FMS
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for FMS with price predictions
Oct 07, 2026

FMS sees its Stochastic Oscillator climbs out of oversold territory

On October 05, 2026, the Stochastic Oscillator for FMS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 55 instances where the indicator left the oversold zone. In 35 of the 55 cases the stock moved higher in the following days. This puts the odds of a move higher at over 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for FMS's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

Following a +2.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where FMS advanced for three days, in 194 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.

FMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FMS as a result. In 47 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

The Moving Average Convergence Divergence Histogram (MACD) for FMS turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 29 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

The Aroon Indicator for FMS entered a downward trend on September 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.855) is normal, around the industry mean (208.195). P/E Ratio (12.151) is within average values for comparable stocks, (175.456). Projected Growth (PEG Ratio) (0.741) is also within normal values, averaging (2.498). FMS's Dividend Yield (0.038) is considerably higher than the industry average of (0.005). P/S Ratio (0.574) is also within normal values, averaging (2.688).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 69 (best 1 - 100 worst), indicating slightly worse than average price growth. FMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 78 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
published Dividends

FMS paid dividends on June 08, 2026

Fresenius Medical Care AG FMS Stock Dividends
А dividend of $0.87 per share was paid with a record date of June 08, 2026, and an ex-dividend date of May 22, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 4.84B. The market cap for tickers in the group ranges from 20.9K to 93.66B. HCA holds the highest valuation in this group at 93.66B. The lowest valued company is NMMCF at 20.9K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was 1%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was 25%. OPCH experienced the highest price growth at 38%, while NIVF experienced the biggest fall at -37%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was -79%. For the same stocks of the Industry, the average monthly volume growth was 170% and the average quarterly volume growth was 91%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 45
Price Growth Rating: 54
SMR Rating: 66
Profit Risk Rating: 87
Seasonality Score: -1 (-100 ... +100)
View a ticker or compare two or three
FMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of renal and dialysis products

Industry HospitalNursingManagement

Industry
Medical Or Nursing Services
Address
Else-Kroner-Strasse 1
Phone
+49 61726090
Employees
109698
Web
https://www.freseniusmedicalcare.com
FMS sees its Stochastic Oscillator climbs out of oversold territory